{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:00:42Z","timestamp":1788454842405,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s12325-024-02796-y","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T09:02:54Z","timestamp":1708074174000},"page":"1462-1480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exposure\u2013Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"Mona","family":"Darwish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Passarell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Youakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathie M.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"2796_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fncel.2014.00018","volume":"8","author":"G Baj","year":"2014","unstructured":"Baj G, Patrizio A, Montalbano A, Sciancalepore M, Tongiorgi E. Developmental and maintenance defects in Rett syndrome neurons identified by a new mouse staging system in vitro. Front Cell Neurosci. 2014;8:18.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"2796_CR2","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/cercor\/bhv078","volume":"26","author":"F Bedogni","year":"2016","unstructured":"Bedogni F, Cobolli Gigli C, Pozzi D, et al. Defects during Mecp2 null embryonic cortex development precede the onset of overt neurological symptoms. Cereb Cortex. 2016;26(6):2517\u201329.","journal-title":"Cereb Cortex"},{"issue":"3","key":"2796_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/cne.22009","volume":"514","author":"PV Belichenko","year":"2009","unstructured":"Belichenko PV, Wright EE, Belichenko NP, et al. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol. 2009;514(3):240\u201358.","journal-title":"J Comp Neurol"},{"key":"2796_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2017.07.002","volume":"76","author":"DG Glaze","year":"2017","unstructured":"Glaze DG, Neul JL, Percy A, et al. A double-blind, randomized, placebo-controlled clinical study of trofinetide in the treatment of Rett syndrome. Pediatr Neurol. 2017;76:37\u201346.","journal-title":"Pediatr Neurol"},{"issue":"16","key":"2796_CR5","doi-asserted-by":"publisher","first-page":"e1912","DOI":"10.1212\/WNL.0000000000007316","volume":"92","author":"DG Glaze","year":"2019","unstructured":"Glaze DG, Neul JL, Kaufmann WE, et al. Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome. Neurology. 2019;92(16):e1912\u201325.","journal-title":"Neurology"},{"key":"2796_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106704","volume":"114","author":"JL Neul","year":"2022","unstructured":"Neul JL, Percy AK, Benke TA, et al. Design and outcome measures of LAVENDER, a phase\u00a03 study of trofinetide for Rett syndrome. Contemp Clin Trials. 2022;114:106704.","journal-title":"Contemp Clin Trials"},{"key":"2796_CR7","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","volume":"29","author":"JL Neul","year":"2023","unstructured":"Neul JL, Percy AK, Benke TA, et al. Trofinetide for the treatment of Rett syndrome: a randomized phase\u00a03 study. Nat Med. 2023;29:1468\u201375.","journal-title":"Nat Med"},{"key":"2796_CR8","doi-asserted-by":"crossref","unstructured":"Neul JL, Percy AK, Benke TA, et al. Trofinetide treatment demonstrates a benefit over placebo for the ability to communicate in Rett syndrome. Pediatr Neurol. 2023;152:63\u201372.","DOI":"10.1016\/j.pediatrneurol.2023.11.005"},{"key":"2796_CR9","doi-asserted-by":"crossref","unstructured":"Darwish M, Passarell J, Maxwell K, Youakim JM, Bradley H, Bishop KM. Weight-based banded dosing to achieve target exposure and exposure\u2013response efficacy analyses to support trofinetide treatment in Rett syndrome. In: Poster presented at: American Society for Clinical Pharmacology and Therapeutics; 22\u201324 March, Atlanta, GA, USA, 2023.","DOI":"10.1007\/s12325-024-02796-y"},{"issue":"8","key":"2796_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/1469-7610.00236","volume":"43","author":"RH Mount","year":"2002","unstructured":"Mount RH, Charman T, Hastings RP, Reilly S, Cass H. The Rett Syndrome Behaviour Questionnaire (RSBQ): refining the behavioural phenotype of Rett syndrome. J Child Psychol Psychiatry. 2002;43(8):1099\u2013110.","journal-title":"J Child Psychol Psychiatry"},{"issue":"13","key":"2796_CR11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1177\/0883073815579707","volume":"30","author":"JL Neul","year":"2015","unstructured":"Neul JL, Glaze DG, Percy AK, et al. Improving treatment trial outcomes for Rett syndrome: the development of Rett-specific anchors for the Clinical Global Impression Scale. J Child Neurol. 2015;30(13):1743\u20138.","journal-title":"J Child Neurol"},{"issue":"6","key":"2796_CR12","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1044\/1092-4388(2002\/097)","volume":"45","author":"AM Wetherby","year":"2002","unstructured":"Wetherby AM, Allen L, Cleary J, Kublin K, Goldstein H. Validity and reliability of the Communication and Symbolic Behavior Scales Developmental Profile with very young children. J Speech Lang Hear Res. 2002;45(6):1202\u201318.","journal-title":"J Speech Lang Hear Res"},{"issue":"5","key":"2796_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1177\/1362361314542955","volume":"19","author":"E Anagnostou","year":"2015","unstructured":"Anagnostou E, Jones N, Huerta M, et al. Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder. Autism. 2015;19(5):622\u201336.","journal-title":"Autism"},{"issue":"6","key":"2796_CR14","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1044\/2015_JSLHR-L-14-0185","volume":"59","author":"A Urbanowicz","year":"2016","unstructured":"Urbanowicz A, Downs J, Girdler S, Ciccone N, Leonard H. An exploration of the use of eye gaze and gestures in females with Rett syndrome. J Speech Lang Hear Res. 2016;59(6):1373\u201383.","journal-title":"J Speech Lang Hear Res"},{"issue":"6","key":"2796_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40261-022-01156-4","volume":"42","author":"M Darwish","year":"2022","unstructured":"Darwish M, Youakim JM, Harlick J, DeKarske D, Stankovic S. A phase\u00a01, open-label study to evaluate the effects of food and evening dosing on the pharmacokinetics of oral trofinetide in healthy adult subjects. Clin Drug Investig. 2022;42(6):513\u201324.","journal-title":"Clin Drug Investig"},{"key":"2796_CR16","doi-asserted-by":"crossref","unstructured":"Darwish M, Nunez R, Youakim JM, Robertson P Jr. Characterization of the pharmacokinetics and mass balance of a single oral dose of trofinetide in healthy male subjects. Clin Drug Investig. 2024;44(1):21\u201333.","DOI":"10.1007\/s40261-023-01322-2"},{"key":"2796_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2020.04.019","volume":"110","author":"E Berry-Kravis","year":"2020","unstructured":"Berry-Kravis E, Horrigan JP, Tartaglia N, et al. A double-blind, randomized, placebo-controlled clinical study of trofinetide in the treatment of fragile X syndrome. Pediatr Neurol. 2020;110:30\u201341.","journal-title":"Pediatr Neurol"},{"key":"2796_CR18","unstructured":"Holford N. The visual predictive check\u2014superiority to standard diagnostic (Rorschach) plots [abstract 738]. Population Approach Group Europe (PAGE) 14; June 16\u201317, 2005; Pamplona, Spain."},{"issue":"1","key":"2796_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s11689-015-9127-4","volume":"7","author":"KV Barnes","year":"2015","unstructured":"Barnes KV, Coughlin FR, O\u2019Leary HM, et al. Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales. J Neurodev Disord. 2015;7(1):30.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"2796_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11689-015-9104-y","volume":"7","author":"R Cianfaglione","year":"2015","unstructured":"Cianfaglione R, Clarke A, Kerr M, et al. A national survey of Rett syndrome: behavioural characteristics. J Neurodev Disord. 2015;7(1):11.","journal-title":"J Neurodev Disord"},{"issue":"2","key":"2796_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ajmg.b.30270","volume":"141B","author":"L Robertson","year":"2006","unstructured":"Robertson L, Hall SE, Jacoby P, Ellaway C, de Klerk N, Leonard H. The association between behavior and genotype in Rett syndrome using the Australian Rett Syndrome Database. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(2):177\u201383.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"2796_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s11689-023-09502-z","volume":"15","author":"JL Neul","year":"2023","unstructured":"Neul JL, Benke TA, Marsh ED, et al. Top caregiver concerns in Rett syndrome and related disorders: data from the US Natural History Study. J Neurodev Disord. 2023;15(1):33.","journal-title":"J Neurodev Disord"},{"key":"2796_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/1088357610380042","volume":"26","author":"TE Bartolotta","year":"2011","unstructured":"Bartolotta TE, Zipp GP, Simpkins SD, Glazewski B. Communication skills in girls with Rett syndrome. Focus Autism Other Dev Disabl. 2011;26:15\u201324.","journal-title":"Focus Autism Other Dev Disabl"},{"issue":"7","key":"2796_CR24","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/09638288.2016.1277392","volume":"40","author":"A Urbanowicz","year":"2018","unstructured":"Urbanowicz A, Ciccone N, Girdler S, Leonard H, Downs J. Choice making in Rett syndrome: a descriptive study using video data. Disabil Rehabil. 2018;40(7):813\u20139.","journal-title":"Disabil Rehabil"},{"key":"2796_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijdevneu.2019.01.001","volume":"73","author":"AP Key","year":"2019","unstructured":"Key AP, Jones D, Peters S. Spoken word processing in Rett syndrome: evidence from event-related potentials. Int J Dev Neurosci. 2019;73:26\u201331.","journal-title":"Int J Dev Neurosci"},{"key":"2796_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ridd.2018.04.004","volume":"82","author":"D Zhang","year":"2018","unstructured":"Zhang D, Roche L, Bartl-Pokorny KD, et al. Response to name and its value for the early detection of developmental disorders: insights from autism spectrum disorder, Rett syndrome, and fragile X syndrome. A perspectives paper. Res Dev Disabil. 2018;82:95\u2013108.","journal-title":"Res Dev Disabil"},{"key":"2796_CR27","volume-title":"Mullen scales of early learning","author":"EM Mullen","year":"1995","unstructured":"Mullen EM. Mullen scales of early learning. Circle Pines: American Guidance Service; 1995."},{"key":"2796_CR28","doi-asserted-by":"crossref","unstructured":"Aylward G. Bayley 4 clinical use and interpretation 1st ed.: Academic (Elsevier). 2020.","DOI":"10.1016\/B978-0-12-817754-9.00001-5"},{"key":"2796_CR29","doi-asserted-by":"crossref","unstructured":"Sparrow SS, Cicchetti DV, Balla DA. Vineland Adaptive Behavior Scales: (Vineland II), Survey Interview Form\/Caregiver Rating Form. 2nd ed. Livonia, MN: Pearson Assessments. 2005.","DOI":"10.1037\/t15164-000"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02796-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-024-02796-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02796-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T09:35:40Z","timestamp":1711186540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-024-02796-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2796"],"URL":"https:\/\/doi.org\/10.1007\/s12325-024-02796-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}